Clinical Trials Browser

Recruiting × Interventional × Depsipeptides × Clear all

NCT03161223 2022-03-31

Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

Phase 1/2 Recruiting

Lymphoma, T-Cell